Note to our followers: Due to a lack of sufficient funding, will cease daily publication of new content at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. If you wish to donate, your gift might help keep the site available to the public for a few more years, by defraying costs of web hosting and maintenance. All of our 6,000+ published articles contain lessons to help people improve their critical thinking about health care. Read more about our change in status. And here's how to make a donation.

Categories: Philadelphia Inquirer


Inquirer’s look at using Facebook to screen for depression emphasizes research ‘is still in very early stages’


Doctor’s $620,000 conflict of interest not disclosed in Inquirer story on new migraine drugs

3 8/10/2018

When n=1, it’s easy to jump to conclusions about a therapy working


Genetic testing to guide antidepressant choices: Big news coverage, but limited evidence


Inquirer delivers well-rounded report on using laughing gas for labor pain–except for two things


Inquirer provides balanced and complete summary of debate over kratom, an herbal opioid


Philadelphia Inquirer story skirts discussion of evidence for experimental migraine drug


Study limitations needed more attention in Inquirer’s look at whooping cough vaccine study


Sleep deprivation for depression: Philadelphia Inquirer gives readers needed context on study limitations


‘O-Shot’ incontinence fix: Inquirer sets out lack of scientific support for procedure